Featured Research

from universities, journals, and other organizations

Cancer doctors have opportunities to cut costs without risk to patients, experts say

Date:
February 14, 2014
Source:
Johns Hopkins Medicine
Summary:
In a review article published, experts identify three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging and drug pricing.

In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging and drug pricing.

Related Articles


"We need to find the best ways to manage costs effectively while maintaining the same, if not better, quality of life among our patients," says Thomas Smith, M.D., The Harry J. Duffey Family Professor of Palliative Medicine and professor of oncology at Johns Hopkins.

Smith and co-author Ronan Kelly, M.D., say that rising numbers of new cancer cases among an aging population are inflating total cancer costs, projected to increase by nearly 40 percent in 2020, and that changing practice patterns should be a priority among oncologists to achieve affordable costs.

"Oncology professional societies, such as the American Society of Clinical Oncology, are beginning to guide oncologists on cost-saving opportunities, but change in routine clinical practice is happening slowly," says Kelly, an assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center.

In the article, Smith and Kelly say the biggest opportunities for safe and ethical cost-cutting solutions rest in caring for patients with metastatic cancer, not on new surgical or radiation treatments, clinical trials, curative care or pediatric care.

For example, the authors suggest that improving end-of-life care with better decision-making and planning could reap large cost savings by reducing hospitalizations in the last month of life. They note that 25 percent of total Medicare costs are spent in the last year of life; 40 percent of which is spent in the last month of life.

"Most people prefer to spend their last days of life at home with family and friends rather than in a hospital, but we still see high rates of hospital utilization in the last month of life," says Smith. Medicare data show that 60 percent of poor-prognosis cancer patients are admitted to a hospital in the last month of life, and 30 percent die there.

The Hopkins team says studies show that hospice care improves symptoms, helps caregivers and costs less, with equal or better survival for patients, yet only half of cancer patients use hospice in their last month of life.

They recommend that patients with poor prognoses have better and earlier discussions with their oncologists about chemotherapy use at the end of life, as well as transitions to hospice. Decision aids spanning these topics have been developed by Smith and colleagues and are endorsed by the American Society of Clinical Oncology.

Unneeded and expensive imaging poses another opportunity to limit costs of care, Smith and Kelly say. PET and other scans, for example, are often used to detect cancer recurrence in patients after initial treatments, but studies show that cure rates are just as good when recurrences are found through other examinations.

"The oncology community needs to have a greater responsibility in evaluating expensive tests, and limit their use to situations where there is strong evidence for benefit," says Kelly.

Finally, the authors suggest that reducing prices of new cancer drugs could help contain cancer costs.

"There are drugs that cost tens of thousands of dollars with an unbalanced relationship between cost and benefit," says Smith. "We need to determine appropriate prices for drugs and inform patients about their costs of care."

One approach, they say, could be to price drugs according to how well they prolong life.

"We need to include patients, pharmaceutical companies and legislators in our efforts to contain cancer care costs, so that we can afford to provide innovative, quality care to future generations," says Smith.


Story Source:

The above story is based on materials provided by Johns Hopkins Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ronan Kelly, Thomas Smith. Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care. The Lancet Oncology, February 2014 DOI: 10.1016/S1470-2045(13)70578-3

Cite This Page:

Johns Hopkins Medicine. "Cancer doctors have opportunities to cut costs without risk to patients, experts say." ScienceDaily. ScienceDaily, 14 February 2014. <www.sciencedaily.com/releases/2014/02/140214075305.htm>.
Johns Hopkins Medicine. (2014, February 14). Cancer doctors have opportunities to cut costs without risk to patients, experts say. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2014/02/140214075305.htm
Johns Hopkins Medicine. "Cancer doctors have opportunities to cut costs without risk to patients, experts say." ScienceDaily. www.sciencedaily.com/releases/2014/02/140214075305.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins